Testosteron – Benzin für den Mann?

Extended Abstract
  • 1 Downloads

Testosterone—fuel for men?

Notes

Einhaltung ethischer Richtlinien

Interessenkonflikt

M. Randazzo gibt an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine vom Autor durchgeführten Studien an Menschen oder Tieren.

Literatur

  1. 1.
    Kallman DA, Plato CC, Tobin JD (1990) The role of muscle loss in the age-related decline of grip strength: cross-sectional and longitudinal perspectives. J Gerontol 45:M82–88CrossRefPubMedGoogle Scholar
  2. 2.
    Orwoll ES, Oviatt SK, McClung MR, Deftos LJ, Sexton G (1990) The rate of bone mineral loss in normal men and the effects of calcium and cholecalciferol supplementation. Ann Intern Med 112:29–34CrossRefPubMedGoogle Scholar
  3. 3.
    Fleg JL, Lakatta EG (1988) Role of muscle loss in the age-associated reduction in VO2 max. J Appl Physiol 65(3):1147–1151CrossRefPubMedGoogle Scholar
  4. 4.
    Horber FF, Gruber B, Thomi F, Jensen EX, Jaeger P (1997) Effect of sex and age on bone mass, body composition and fuel metabolism in humans. Nutrition 13:524–534CrossRefPubMedGoogle Scholar
  5. 5.
    Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR, Baltimore Longitudinal Study of Aging (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86:724–731CrossRefPubMedGoogle Scholar
  6. 6.
    Morley JE, Kaiser FE, Perry HM 3rd, Patrick P, Morley PM, Stauber PM, Vellas B, Baumgartner RN, Garry PJ (1997) Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 46:410–413CrossRefPubMedGoogle Scholar
  7. 7.
    Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O’Neill TW, Bartfai G, Casanueva F, Forti G, Giwercman A, Huhtaniemi IT, Kula K, Punab M, Boonen S, Vanderschueren D, European Aging Study MG (2008) Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 93:2737–2745CrossRefPubMedGoogle Scholar
  8. 8.
    Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, O’Neill TW, Bartfai G, Casanueva FF, Forti G, Giwercman A, Han TS, Kula K, Lean ME, Pendleton N, Punab M, Boonen S, Vanderschueren D, Labrie F, Huhtaniemi IT, Group E (2010) Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 363:123–135CrossRefPubMedGoogle Scholar
  9. 9.
    Chute CG, Baron JA, Plymate SR, Kiel DP, Pavia AT, Lozner EC, O’Keefe T, MacDonald GJ (1987) Sex hormones and coronary artery disease. Am J Med 83:853–859CrossRefPubMedGoogle Scholar
  10. 10.
    Laughlin GA, Barrett-Connor E, Bergstrom J (2008) Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 93:68–75CrossRefPubMedGoogle Scholar
  11. 11.
    Tivesten A, Vandenput L, Labrie F, Karlsson MK, Ljunggren O, Mellstrom D, Ohlsson C (2009) Low serum testosterone and estradiol predict mortality in elderly men. J Clin Endocrinol Metab 94:2482–2488CrossRefPubMedGoogle Scholar
  12. 12.
    Muraleedharan V, Marsh H, Kapoor D, Channer KS, Jones TH (2013) Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes. Eur J Endocrinol 169:725–733CrossRefPubMedGoogle Scholar
  13. 13.
    Dong JY, Zhang YH, Qin LQ (2011) Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol 58:1378–1385CrossRefPubMedGoogle Scholar
  14. 14.
    Lunenfeld B, Mskhalaya G, Zitzmann M, Arver S, Kalinchenko S, Tishova Y, Morgentaler A (2015) Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male 18:5–15CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Jones TH, Arver S, Behre HM, Buvat J, Meuleman E, Moncada I, Morales AM, Volterrani M, Yellowlees A, Howell JD, Channer KS, Investigators T (2011) Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care 34:828–837CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Saad F, Aversa A, Isidori AM, Zafalon L, Zitzmann M, Gooren L (2011) Onset of effects of testosterone treatment and time span until maximum effects are achieved. Eur J Endocrinol 165:675–685CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Hackett G (2016) An update on the role of testosterone replacement therapy in the management of hypogonadism. Ther Adv Urol 8:147–160CrossRefPubMedGoogle Scholar
  18. 18.
    Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM, Eder R, Tennstedt S, Ulloor J, Zhang A, Choong K, Lakshman KM, Mazer NA, Miciek R, Krasnoff J, Elmi A, Knapp PE, Brooks B, Appleman E, Aggarwal S, Bhasin G, Hede-Brierley L, Bhatia A, Collins L, LeBrasseur N, Fiore LD, Bhasin S (2010) Adverse events associated with testosterone administration. N Engl J Med 363:109–122CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Budoff MJ, Ellenberg SS, Lewis CE, Mohler ER 3rd, Wenger NK, Bhasin S, Barrett-Connor E, Swerdloff RS, Stephens-Shields A, Cauley JA, Crandall JP, Cunningham GR, Ensrud KE, Gill TM, Matsumoto AM, Molitch ME, Nakanishi R, Nezarat N, Matsumoto S, Hou X, Basaria S, Diem SJ, Wang C, Cifelli D, Snyder PJ (2017) Testosterone treatment and coronary artery plaque volume in older men with low testosterone. JAMA 317:708–716CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, Gill TM, Barrett-Connor E, Swerdloff RS, Wang C, Ensrud KE, Lewis CE, Farrar JT, Cella D, Rosen RC, Pahor M, Crandall JP, Molitch ME, Cifelli D, Dougar D, Fluharty L, Resnick SM, Storer TW, Anton S, Basaria S, Diem SJ, Hou X, Mohler ER 3rd, Parsons JK, Wenger NK, Zeldow B, Landis JR, Ellenberg SS, Testosterone Trials I. (2016) Effects of testosterone treatment in older men. N Engl J Med 374:611–624CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.Klinik für Urologie, EBU Certified Training CenterKantonspital WinterthurWinterthurSchweiz

Personalised recommendations